Evommune, Inc.
EVMN
$18.87
-$0.02-0.11%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 10.00M | 0.00 | 3.00M | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 10.00M | 0.00 | 3.00M | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | 10.00M | 0.00 | 3.00M | -- | |
| SG&A Expenses | 3.69M | 3.36M | 3.67M | 3.23M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 23.33M | 22.99M | 18.03M | 16.52M | |
| Operating Income | -13.33M | -22.99M | -15.03M | -16.52M | |
| Income Before Tax | -12.48M | -13.57M | -14.56M | -15.92M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -12.48M | -13.57M | -14.56M | -15.92M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -12.48M | -13.57M | -14.56M | -15.92M | |
| EBIT | -13.33M | -22.99M | -15.03M | -16.52M | |
| EBITDA | -13.02M | -22.62M | -14.66M | -16.19M | |
| EPS Basic | -8.07 | -8.80 | -9.48 | -10.47 | |
| Normalized Basic EPS | -5.05 | -5.50 | -5.93 | -6.54 | |
| EPS Diluted | -8.07 | -8.80 | -9.48 | -10.47 | |
| Normalized Diluted EPS | -5.05 | -5.50 | -5.93 | -6.54 | |
| Average Basic Shares Outstanding | 1.55M | 1.54M | 1.54M | 1.52M | |
| Average Diluted Shares Outstanding | 1.55M | 1.54M | 1.54M | 1.52M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |